Anna Galkin
![Anna Galkin Anna Galkin](https://sting-tlr-targeting-therapies.com/wp-content/uploads/sites/457/2024/02/Anna-Galkin-150x150.jpg)
Company: Axelia Oncology
Job title: Chief Scientific Officer
Seminars:
Developing a Systemically Delivered TLR2 Agonist for Cancer Immunotherapy 3:30 pm
Understand the mechanistic rationale for pursuing TLR2 agonists in CPI resistant solid tumor indications Review the safety and tolerability profile of AXA-042 demonstrated in the first-in-human clinical trial Translational lessons from the clinic: impact of TLR2 target engagement on clinical safety and response biomarkers Read more
day: Conference Day 2